# Clofarabine Therapy in Locally Advanced or Metastatic Urothelial Carcinoma

> **NCT07034053** · PHASE1,PHASE2 · RECRUITING · sponsor: **Ekaterina Laukhtina** · enrollment: 50 (estimated)

## Conditions studied

- Advanced Urothelial Carcinoma
- Metastatic Urothelial Cancer

## Interventions

- **DRUG:** Clofarabine

## Key facts

- **NCT ID:** NCT07034053
- **Lead sponsor:** Ekaterina Laukhtina
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-24
- **Primary completion:** 2028-11
- **Final completion:** 2028-11
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07034053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07034053, "Clofarabine Therapy in Locally Advanced or Metastatic Urothelial Carcinoma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07034053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*